Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: mike head who wrote (189)	3/7/1998 8:31:00 PM
From: Henry Niman	Respond to of 656

mike, I don't think that there would be a patent battle. The small molecules are not the peptide hormone or anything like the peptide hormone (they don't even have a peptide bond), so it's hard to see how AMGN or IMNX could cover them with a patent. When LGND knew it worked (which was a major surprise), they filed patents, but I think that AMGN and IMNX can only make a lot of noise regarding a molecule that they had no idea would work. I think that the discovery is causing a great deal of excitement and the me toos are lining up (but not behind AMGN or IMNX).

To: mike head who wrote (189)	3/7/1998 10:25:00 PM
From: Henry Niman	Respond to of 656

mike, I have updated the SBH Alliance Table at home.att.net to include more details of the little molecule that mimics G-CSF (with exquisite specificity) as well as a few recently (1998) issued relevant patents.